PVI
SPPI

Pura Vida Investments’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Pura Vida Investments’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-218,000
Closed -$794K – 136
2019
Q4 		$794K Buy
+218,000
New +$1.76M 0.07% 95
2018
Q3 		– Sell
-130,700
Closed -$2.74M – 142
2018
Q2 		$2.74M Buy
130,700
+30,700
+31% +$569K 1.1% 30
2018
Q1 		$1.61M Buy
+100,000
New +$1.98M 0.95% 36

Other funds holding SPPI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pura Vida Investments's SPPI Position: Q4 2018 in Review

Pura Vida Investments sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 50,000 shares — an estimated $840K sold.

Pura Vida Investments first reported a position in SPPI in Q3 2018 and held it in 1 quarter. The position peaked at $840K in Q3 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

  • Pura Vida Investments reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Pura Vida Investments sold 50,000 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $840K.
  • Pura Vida Investments first reported a position in Spectrum Pharmaceuticals Inc in Q3 2018 and held it in 1 quarter.
  • Pura Vida Investments's Spectrum Pharmaceuticals Inc position peaked at $840K in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on Pura Vida Investments's 13F filing for Q4 2018, filed 14 Feb 2019.